This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ahmed, R. and Biron, C.A., 1999, Immunity to viruses. In: Fundamental Immunology, (W.E. Paul, ed.) Lippincott-Raven, Philadelphia; pp. 1295–1334
Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y., and Friih, K., 1996b, Human cytomegalo virus inhibits antigen presentation by a sequential multistep process., Proc. Nad. Acad. Sci. USA 93:10990–10995
Ahn, K., Gruhler, A., Galocha, B., Jones, T.R., Wiertz, E.J.H.J., Ploegh, H. L., Peterson, P. A., and Früh, K., 1997, The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613–621
Ahn, K., Meyer, T.H., Uebel, S., Sempe, P., Djaballah, H., Yang, Y., Peterson, P.A., Früh, K., Tampe, R., 1996a, Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 15:3247–3255
Bahram, S., Bresnahan, M., Geraghty, D.E. and Spies, T., 1994, A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 91:6259–6263
Beersma, M.F.C., Bijlmakers, M.J.E., and Ploegh, H.L., 1993, Cytomegalovirus downregulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455–4464
Benz, C. and Hengel, H., 2000, MHC class I-subversive gene functions of Cytomegalovirus and their regulation by interferons — an intricate balance. Virus Genes 21:39–47
Benz, C., Reusch, U., Muranyi, W., Brune, W., Atalay, R., and Hengel, H., 2001, Efficient downregulation of major histocompatibilty complex class I molecules in human epithelial cells infected with Cytomegalovirus. J. Gen. Virol. 82: 2061–2070
Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E., Brooks, A.G., 1998, Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:813–818
Braud, V.M., Allan, D.S., Wilson, D., McMichael, A.J., 1998a, TAP-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1–10
Braud, V.M., Allan, D.S., O’Callaghan, C.A., Soderstrom, K., D’Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., Lanier, L.L., McMichael, A.J., 1998b, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795–799
Chee, M. S,, Bankier, A.T., Beck, S., Bohni, R., Brown, C.M., Cerny, R., Horsnell, T., Hutchison, C.A. 3d, Kouzarides, T., Martignetti, J.A., Preddi, E., Satchwell, S.C., Tomlinson, P., Weston, K.M., Barrell, B.G., 1990, Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125–169
Cosman, D., Müllberg, J., Sutherland, C.L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., and Chalupny, n.J., 2001, ULBPs, novel MHC class I-related molelcules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–133
Del Val, M., Hengel, H., Häcker, H., Hartlaub, U., Ruppert, T., Lucin, P. and Koszinowski, U. H., 1992, Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 172:729–738
Del Val, M., Münch, K., Reddehase, M.J., Koszinowski, U.H., 1989, Presentation of cytomegalovirus immediate-early antigens to cytolytic T lymphocytes is selectively blocked by viral genes expressed in the early phase. Cell 58:305–315
Früh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P.M., Tampe, R., Peterson, P.A., Yang, Y. 1995, A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415–418
Geginat, G., Ruppert, T., Hengel, H., Holtappels, R., and Koszinowski, U.H., 1997, IFN-γ is a prerequisite for optimal antigen processing of viral peptides in vivo. J. Immunol. 158:3303–3310
Gewurz, B.E., Wang, E.W., Tortorella, D., Schust, D.J., and Ploegh, H.L., 2001, Human cytomegalovirus US2 endoplasmic reticulum domain dictates association with major histocompatibility complex class I in a locus-specific manner. J. Virol. 75:5197–5204
Groh, V., Bahrain, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T., 1996, Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445–12450
Heemels, M. T., and H. L. Ploegh. Generation, translocation, and presentation of MHC class I-restricted peptides. 1995. Annu. Rev. Biochem. 64:463–491.
Heise, M., Connick, M., and Virgin, H.W., 1998, Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1037–1046
Hengel, H., Brune, W., and Koszinowski, U.H. 1998, Immune evasion by cytomegalovirus — survival strategies of a highly adapted opportunist. Trends Microbiol. 6:190–197
Hengel, H., Eßlinger, C., Pool, J., Goulmy, E., and Koszinowski, U.H., 1995, Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J. Gen. Virol. 76:2987–2997
Hengel, H., Flohr, T., Hämmerling, G.H., Koszinowski, U.H., and Momburg, F., 1996, Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:2287–2296
Hengel, H., Koopmann, J.O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G.J., Koszinowski, U.H., and Momburg, F., 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623–632
Hengel, H., and Koszinowski, U.H., 1997, Interference with antigen processing by viruses. Cur. Opin. Immunol., 9:470–476
Hengel, H., Lucin, P., Jonjic, S., Ruppert, T., and Koszinowski, U.H., 1994, Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289–297
Hengel, H., Reusch, U., Geginat, G., Holtappels, R., Ruppert, T., Hellebrand, E., and Koszinowski, U.H., 2000, Macrophages escapeinhibition of major histocompatibility complex class I dependent antigen presentation by cytomegalovirus. J. Virol. 74:7861–7868
Hengel, H., Reusch, U., Gutermann, A., Ziegler, H., Jonjic, S., Lucin, P., and Koszinowski U.H., 1999, Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 168:167–176
Hewitt, E.W., Sen Gupta, S. and Lehner P.J., 2001, The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20:387–396
Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., Johnson, D. 1995, Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411–415
Huard, B., Früh, K., 2000, A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur. J. Immunol. 30:509–515
Jones, T.R., Hanson, L.K., Sun, L., Slater, J.S., Stenberg, R.S. and Campbell, A.E., 1995, Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830–4841
Jones, T. R. and Muzithras, V. P., 1991, Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169. J. Virol. 65:2024–2036
Jones, T.R., and Sun, L., 1997, Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970–2979
Jones, T.R., Wiertz, E.J.H.J., Sun, L., Fish, K., Nelson, J.A. and Ploegh, H.L., 1996, Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93:11327–11333
Jonjic, S., Del Val, M., Keil, G.M., Reddehase, M.J. and Koszinowski, U.H., 1988, A nonstmctural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J. Virol. 62:1653–1658
Jonjic, S., Mutter, W., Weiland, F., Reddehase, M.J., and Koszinowski, U.H., 1989, Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med 169:1199–1212
Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P., and Koszinowski, U.H., 1994, Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713–1717
Jun, Y., Kim, E., Jin, M., Sung, H.C., Han, H., Geraghty, D.E., Ahn, K., 2000, Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J. Immunol. 164:805–811
Kärre, K., 1995, Express yourself or die: peptides, MHC molecules, and NK cells. Science 267:978–979
Kaye, J., Browne, H., Stoffel, M., and Minson, T., 1992, The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J. Virol. 66:6609–6615
Kleijnen M., Huppa, J.B., Lucin, P., Mukherjee, P., Farrell, H., Campbell, A., Koszinowski, U.H., Hill, A.B. and Ploegh, H.L., 1997, A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but transported to the cell surface. EMBO J. 16:685–694
Krmpotic, A., Bubic, I., Hengel, H., Scalzo, A., Koszinowski, U.H., and Jonjic, S., 2001, The MCMV m152/gp40 glycoprotein achieves simultaneous avoidance of CD8+ and NK cell-mediated immune control. Abstract. International Cytomegalovirus Workshop, Asilomar, CA, USA
Krmpotic, A., Messerle, M., Crnkovic-Mertens, I., Polic, B., Jonjic, S., and Koszinowski, U. H., 1999, The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell conctrol in vivo. J. Exp. Med. 190:1285–1295
Lee, N., Goodlett, D.R., Ishitani, A., Marquardt, H., Geraghty, D.E., 1998b, HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951–1960
Lehner, P.J., Karttunen, J.T., Wilkinson, G.W.G. and Cresswell, P., 1997, The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94:6904–6909
Lindquist J.A., Jensen, O.N., Mann, M., and Hämmerling, G.J., 1998, ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 17:2186–2195
Lucin, P., Pavic, I., Polic, B., Jonjic, S., and Koszinowski, U.H., 1992, Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977–1984
Miller, D.M., Rahill, B.M., Boss, J.M., Lairmore, M.D., Durbin, J.E., Waldman, W.J., Sedmak, D.D., 1998, Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med, 187:675–683
Mocarski, E.S., 1996, Cytomegaloviruses and their replication. In: Virology, (B.N. Fields, D.M. Knipe, and P.M. Howley, eds.) Volume 2. Lippincott-Raven, Philadelphia; pp. 2447–2492
Momburg, F. and Hämmerling, G.J., 1998, Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv. Immunol. 68:191–256
Momburg F. and Hengel, H., 2001, Corking the bottle neck: the transporter associated with antigen processing (TAP) as a target for immune subversion by viruses. Curr. Top. Microbiol. Immunol., in press
Ortmann, B., Androlewicz, M., and Cresswell, P., 1994, MHC class I / β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864–867
Pavic, I., Polic, B., Crnkovic, I., Lucin, P., Jonjic, S., and Koszinowski, U.H., 1993, Participation of endogenous tumour necrosis factor α in host resistance to cytomegalovirus infection. J. Gen. Virol., 74:2215–2223
Ploegh, H.L., 1998, Viral Strategies of immune evasion. Science 280:248–253.
Polic, B., Hengel, H., Krmpotic, A., Trgovcich, J., Pavic, I., Lucin, P., Jonjic, S., Koszinowski, U.H., 1988, Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188:1047–1054
Rawlinson, W.D., Farrell, H.E., Barrell, B.C., 1996, Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833–8849
Reddehase, M.J., Mutter, W., Münch, K., Burning, H.J., and Koszinowski, U.H., 1987, CD8 positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61:3102–3108
Reddehase, M.J., Weiland, F., Munch, K., Jonjic, S., Lüske, A., and Koszinowki, U.H., 1985, Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264–273
Reits, E.A., Vos, J.C., Gromme, M., Neefjes, J., 2000, The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774–778
Reusch, U., Muranyi, W., Lucin, P., Burgert, H.G., Hengel, H., and Koszinowski, U.H., 1999, A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1081–1091
Riddell, S.R., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E., and Greenberg, P.D., 1992, Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238–241
Rock, K.L., and Goldberg, A.L., 1999, Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739–779
Sadasivan, B., Lehner, P.J., Ortmann B, Spies, T., and Cresswell P., 1996, Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103–114
Schust, D.J., Tortorella, D., Seebach, J., Phan, C., and Ploegh, H.L., 1998, Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188:497–503
Shamu, C.E., Story, C.M., Rapoport, T.A., and Ploegh, H.L., 1999, The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J. Cell Biol. 147:45–57
Shellam, G.R., Allan, J.E., Papadimitriou, J.M., and Bancroft, G.J., 1981, Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA 78:5104–5108
Sinzger, C., Grefte, A., Plachter, B., Gouw, A.S.H., The, T.H. and Jahn, G., 1995, Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:741–750
Story, C.M., Furman, M.H., and Ploegh, H.L., 1999, The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US 11 gene products. Proc. Natl. Acad. Sci. USA 96:8516–8521
Suh, W.K., Cohen-Doyle, M.F., Früh, K., Wang, K., Peterson, P.A., Williams, D.B., 1994, Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322–1326
Thale, R., Szepan, U., Hengel, H., Geginat, G., Lucin, P., Koszinowski, U.H., 1995, Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69:6098–6105
Tomasec, P., Braud, V.M., Rickards, C., Powell, M.B., McSharry, B.P., Gadola, S., Cerundolo. V., Borysiewicz, L.K., McMichael, A.J., Wilkinson, G.W., 2000, Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031–1033
Tomazin, R., Boname, J., Hegde, N., Lewinsohn, D.M., Altschuler, Y., Jones, T.R., Cresswell, P., Nelson, J.A., Riddell, S., and Johnson, D.C., 1999, Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 9:1039–1043.
Tomazin, R., Hegde, N., and Johnson, D.C., 2001, Inhibition of MHC class I and II antigen presentation by herpesviruses. Abstract. Keystone Symposium on Molecular Aspects of Viral Immunity, Keystone, Co, USA.
Tomazin, R., Hill, A.B., Jugovic, P., York, I., van Endert, P., Ploegh, H.L., Andrews, D.W., Johnson, D.C., 1996, Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15:3256–3266
Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J.W., Pla, M., Weiss, E.H., 2000, Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164:5019–5022
Warren, A.P, Ducroq, D.H,, Lehner, P.J. and Borysiewicz, L.K., 1994, Human-cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:2822–2829.
Welsh, R.M., Brubaker, J.O., Vargas-Cortes, M., and O’Donnell, C.L., 1991, Natural Killer (NK) cell responses to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK-dependent control of virus infections occur independently of T and B cell funtion. J. Exp. Med. 173:1053–1063
Wiertz, E.J H.J., Jones, T.R., Sun, L., Bogyo, M., Geuze, H.J. and Ploegh, H.L., 1996a, The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769–779
Wiertz, E.J.H.J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T.R., Rapoport, T.A. and Ploegh, H.L., 1996b, Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432–438
Yamashita, Y., Shimokata, K., Mizuno, S., Yamaguchi, H. and Nishiyama, Y., 1993, Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology 193:727–736
Ziegler, H., Muranyi, W., Burgert, H.-G., Kremmer, E., and Koszinowski, H.U., 2000, The luminal part of the murine cytomegalovirus glycoprotein gp40 catlayzes the retention of MHC class I molecules, EMBO J. 19:870–881
Ziegler, H., R. Thäle, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farell, W. Rawlinson, and U.H. Koszinowski, 1997, A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi. Immunity 6:57–66
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Zimmermann, A., Halenius, A., Hengel, H. (2002). Cytomegalovirus Glycoproteins Interacting with MHC Class I Molecules and the MHC-encoded Peptide Transporter. In: Holzenburg, A., Bogner, E. (eds) Structure-Function Relationships of Human Pathogenic Viruses. Springer, Boston, MA. https://doi.org/10.1007/0-306-47650-9_15
Download citation
DOI: https://doi.org/10.1007/0-306-47650-9_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46768-4
Online ISBN: 978-0-306-47650-1
eBook Packages: Springer Book Archive